Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04876313
Title An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) (NURE-Combo)
Acronym NURE-Combo
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.